Skip to content

The Degree, Duration and Frequency of Insulin Resistance in Non-operated Patients With Sepsis

Insulin Resistance in Septic Patients in the Acute Phase and After Discharge From Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04969159
Enrollment
18
Registered
2021-07-20
Start date
2018-09-01
Completion date
2021-03-01
Last updated
2021-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

septicaemia, insulin resitance, continous blood glucose

Brief summary

Surgery induces insulin resistance lasting for 2-3 weeks. We wanted to elucidate if stress-metabolic, medical conditions carry the same effect.

Detailed description

Background: Insulin resistance is well documented after surgery in a severity positively correlated to the degree of trauma (Thorell et al. 1999; Chambrier et al. 2000). Similar phenomena have been described in severely ill patients in ICU with consequences for the survival (Van den Berghe et al. 2001; The NICE-SUGAR Study Investigators 2009). The documentation, however, is scarce and the extent is unknown in acutely ill patients with sepsis. Method: Adult, consecutive, non-diabetic patients with elevated CRP, leukocyte counts, SOFA-score of ≥ 2 were monitored with fasting p-C-peptide, blood glucose, CRP, leukocyte count and HOMA-IR at admittance, discharge and at two follow-up visits 2 weeks and 4 weeks after admission. Blood glucose levels were measured continuously during the whole study period with a flash glucose monitor mounted on the patients' upper arm. The diagnosis was sepsis, urosepsis, pneumonia, erysipecosis, bacteremia, infection with unknow focus and covid-19.

Interventions

OTHERno intervention

standard treatment in the clinical routine

Sponsors

Jens Rikardt Andersen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* elevated CRP on acute asdmission * elevated leukocyte count on admission * SOFA-score ≥ 2 * diagnosis: bacterial sepsis * full age and authority

Exclusion criteria

* not able to understand the protocol * not able to co-operate * diabetes mellitus of any kind

Design outcomes

Primary

MeasureTime frameDescription
continous blood glucose4 weeksflash glucose monitor on the upper arm

Secondary

MeasureTime frameDescription
C-peptide4 weeksplasma concentration
HOMA-IR4 weekscalculated glucose load test

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026